200
Participants
Start Date
April 30, 2025
Primary Completion Date
October 31, 2025
Study Completion Date
February 28, 2026
Sarcopenia tests (for muscle mass, muscle function, physical performance)
We are not aware of any other study performing sarcopenia tests in GDM (or in pregnancy in general), with the aim of assessing sarcopenia prevalence in GDM/pregnancy, and related possible adverse pregnancy outcomes.
Oral Glucose Tolerance Test
The OGTT, in combination with the sarcopenia tests, will allow to explore the relationships between the glucometabolic condition and the muscle quality in the pregnant women, either with GDM or with normal glucose tolerance.
Montreal Cognitive Assessment
The MoCA questionnaire, in combination with the sarcopenia tests, will allow to explore the relationships between the cognitive function the presence of the sarcopenia syndrome in the pregnant women, either with GDM or with normal glucose tolerance.
Department of Obstetrics and Gynaecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna, Vienna
Institute of Neuroscience, National Research Council, Padua
Department of Clinical and Experimental Medicine, University of Pisa, Pisa
University of Pisa
OTHER
Medical University of Vienna
OTHER
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche
NETWORK